45,144 Shares in Merck KGaA $MKGAF Purchased by Bontempo Ohly Capital Mgmt LLC

Bontempo Ohly Capital Mgmt LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 45,144 shares of the company’s stock, valued at approximately $5,801,000. Merck KGaA comprises about 2.5% of Bontempo Ohly Capital Mgmt LLC’s portfolio, making the stock its 4th biggest position.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MKGAF. Gables Capital Management Inc. bought a new position in shares of Merck KGaA in the second quarter worth about $2,095,000. Diversify Advisory Services LLC acquired a new position in shares of Merck KGaA during the second quarter worth approximately $3,810,000. Danske Bank A S bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $276,535,000. Danica Pension Livsforsikringsaktieselskab bought a new stake in shares of Merck KGaA during the second quarter valued at approximately $25,541,000. Finally, BOK Financial Private Wealth Inc. acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $523,000. Institutional investors and hedge funds own 0.10% of the company’s stock.

Merck KGaA Stock Performance

MKGAF stock opened at $164.58 on Thursday. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a 50 day moving average price of $163.19 and a 200 day moving average price of $148.83. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The stock has a market capitalization of $21.27 billion, a PE ratio of 25.13 and a beta of 0.96.

Merck KGaA Company Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.